Research roundup: Recent grants and publications for Emory faculty and staff
Emory News Center
12 April 2022https://news.emory.edu/stories/2022/04/er_research_roundup_april_14-04-2022/story.html

Among others, a grant is: Low dose naltrexone to be studied for chronic neuropathic pain

Response to: Invasive Treatments for Low Back Disorders and the ACOEM Practice Guidelines

J Occup Environ Med
01 February 2022
https://journals.lww.com/joem/Fulltext/2022/02000/Response_to__Invasive_Treatments_for_Low_Back.20.aspx

Low-dose naltrexone, an opioid-receptor antagonist, is a broad-spectrum analgesic: a retrospective cohort study

Pain Manag
15 March 2022
https://pubmed.ncbi.nlm.nih.gov/35289682/

Aim: To evaluate the use of low-dose naltrexone (LDN) as a broad-spectrum analgesic.

How a Drug for Opioid and Alcohol Addiction Is Helping Treat Long COVID

The Epoch Times
26 March 2022
https://www.theepochtimes.com/how-a-drug-for-opioid-and-alcohol-addiction-is-helping-treat-long-covid_4363132.html

A drug that’s helping millions of people with opioid or alcohol dependence is also being used to treat those suffering symptoms of long COVID.

Nonopioid Analgesic, Nonpharmacologic Options for Pain Management Reviewed

Drug Topics
24 March 2022
https://www.drugtopics.com/view/nonopioid-analgesic-nonpharmacologic-options-for-pain-management-reviewed

Dry eye research reveals impact of disease, potential new treatments

Healia Optometry
10 March 2022
https://www.healio.com/news/optometry/20220310/dry-eye-research-reveals…

Topical Therapeutic Options in Corneal Neuropathic Pain  (Abstract)

Front Pharmacol
31 January 2022
https://pubmed.ncbi.nlm.nih.gov/35173607/